Lv1
60 积分 2024-04-22 加入
Trispecific anti-CD3/BCMA/CD38 antibodies for multiple myeloma: a patent evaluation of US20240132615
1个月前
已完结
Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma models
1个月前
已完结
From Guidelines to Implementation: A Case Study on Applying ICH M10 for Bioanalytical Assay Cross-Validation
7个月前
已完结
〈1106.1〉 Immunogenicity Assays—Design and Validation of Assays to Detect Anti-Drug Neutralizing Antibody
10个月前
已关闭
SAP-expressing T peripheral helper cells identify systemic lupus erythematosus patients with lupus nephritis
11个月前
已完结
An industry perspective on hyaluronidase co-formulated biopharmaceutics
1年前
已完结
皖公网安备34019202002308
